At what pace is the embolotherapy market growing, and what is its estimated value?
The embolotherapy market size has grown strongly in recent years. It will grow from $4.44 billion in 2024 to $4.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising demand for embolotherapy to treat cases, increasing incidence of cancer, increasing incidence of peripheral vascular diseases, increasing healthcare expenditure, and increasing investment for research.
The embolotherapy market size is expected to see strong growth in the next few years. It will grow to $6.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising disposable income, increasing prevalence of chronic diseases, growing adoption in reproductive health, increasing number of cheoembolization procedures, and rising incidence of liver cancer. Major trends in the forecast period include cutting edge technologies, digital and analog devices, insertable cardiac monitor, embolotherapy techniques, and strategic collaboration.
Get Your Free Sample of The Global Embolotherapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp
What are the top drivers to the rising demand in the embolotherapy market?
The rising preference for minimally invasive procedures is expected to propel the growth of the embolotherapy market going forward. Minimally invasive procedures refer to cosmetic treatments that require little to no surgical intervention, typically involving minimal downtime and lower risks. The rising preference for minimally invasive procedures is driven by faster recovery, reduced pain, more minor scars, lower complication risks, and technological advances. Embolotherapy enhances minimally invasive procedures by selectively blocking blood flow to targeted vessels, reducing bleeding, treating tumors, and managing vascular abnormalities with greater precision and fewer complications. For instance, in September 2023, according to the American Society of Plastic Surgeons, a US-based non-profit organization, cosmetic minimally invasive procedures grew by 7% in 2023, reaching 25,442,640, up from 23,672,269 in 2022. Therefore, the rising preference for minimally invasive procedures is driving the growth of the embolotherapy market.
How is the embolotherapy market segmented?
The embolotherapy market covered in this report is segmented –
1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders
3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)
4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users
Subsegments:
1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles
3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5) By Support Devices: Guidewires, Catheters, Sheath Introducers
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report
Who are the top competitors in the embolotherapy market?
Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc
What significant trends should we anticipate in the embolotherapy market over the forecast period?
Major companies operating in the embolotherapy market are focusing on developing innovative products such as absorbable embolics systems to enhance patient outcomes and expand treatment options. Absorbable embolic systems refer to bioresorbable materials used in embolization procedures to block blood flow to target tissues, such as tumors or aneurysms, while gradually degrading within the body over time. For instance, in January 2025, Instylla Inc., a US-based medical equipment manufacturing company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system, a bioresorbable embolization agent made of irregularly shaped, dry-gelatin particles sized between 85 and 255 µm. The system is designed to embolize hypervascular tumors and occluding blood vessels in the peripheral vasculature. According to Instylla, Tembo offers advantages such as easy preparation, high visibility, and the ability to densely pack treated vessels densely, potentially improving existing permanent embolic solutions.
Which regional trends are influencing the embolotherapy market, and which area dominates the industry?
North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Embolotherapy Market Report 2025 Offer?
The embolotherapy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Embolotherapy is a minimally invasive medical procedure involving intentionally blocking blood vessels to treat various medical conditions. It is achieved by injecting embolic agents, such as microspheres, coils, gels, or liquid embolic, into targeted blood vessels to cut off blood supply to abnormal tissues or structures. Embolotherapy is a highly targeted and less invasive alternative to traditional surgery, often performed by interventional radiologists to improve patient outcomes with minimal recovery time.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
